Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00598858
What this trial is testing

Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+1 more
John P. Fruehauf
Not applicableStudy completedNCT02550704
What this trial is testing

Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients

Who this might be right for
Irritable Bowel Syndrome
University Hospital, Rouen 34
Not applicableNot Yet RecruitingNCT07804693
What this trial is testing

Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Vascular DiseaseHigh Altitude+2 more
Silvia Ulrich Somaini 20
Early research (Phase 1)Study completedNCT02604004
What this trial is testing

Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers

Who this might be right for
HIV INFECTIONS
Universidade Federal de Pernambuco 28
Early research (Phase 1)Study completedNCT02027129
What this trial is testing

Physiological Study of Low-frequency HFO/HFO-TGI and High-frequency HFO

Who this might be right for
Acute Respiratory Distress SyndromeAcute Cor Pulmonale
University of Athens 17
Testing effectiveness (Phase 2)UnknownNCT01909388
What this trial is testing

Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Alfonso Gomez-Iturriaga 15
Not applicableStudy completedNCT01970969
What this trial is testing

THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring

Who this might be right for
Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation
Scripps Translational Science Institute 928
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616336
What this trial is testing

Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Zhongshan Hospital (Xiamen), Fudan University 15
Not applicableStudy completedNCT03694535
What this trial is testing

Intravesical Thermochemotherapy With Mitomycin-c

Who this might be right for
Bladder Cancer
TC Erciyes University 44
Testing effectiveness (Phase 2)Study completedNCT03113617
What this trial is testing

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma
Andrei Iagaru 44
Large-scale testing (Phase 3)UnknownNCT05446324
What this trial is testing

Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer

Who this might be right for
Endometrial Cancer
UMC Utrecht 10
Not applicableWithdrawnNCT02546427
What this trial is testing

Hypofractionated Whole Pelvic Radiotherapy of the Prostate

Who this might be right for
Prostate Cancer
Albert J. Chang
Testing effectiveness (Phase 2)Study completedNCT03715946
What this trial is testing

Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckOropharynx Squamous Cell Carcinoma
Robert L. Ferris, MD, PhD 40
Not applicableStudy completedNCT06316882
What this trial is testing

Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program

Who this might be right for
Gastric CancerGastric (Stomach) CancerAtrophic Gastritis+3 more
Unidade Local De Saúde Do Norte Alentejano 349
Large-scale testing (Phase 3)Study completedNCT00696735
What this trial is testing

High-Dose Therapy Treatment in Patients With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
French Innovative Leukemia Organisation 172
Not applicableNot Yet RecruitingNCT07804589
What this trial is testing

Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals

Who this might be right for
High AltitudeHealthyHealthy Adult+4 more
Silvia Ulrich Somaini 14
Testing effectiveness (Phase 2)Study completedNCT05254899
What this trial is testing

Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)

Who this might be right for
Extranodal NK-T-Cell LymphomaEarly-stageHigh-Risk Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 54
Testing effectiveness (Phase 2)Looking for participantsNCT07097363
What this trial is testing

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more
University of Washington 18
Testing effectiveness (Phase 2)UnknownNCT06201507
What this trial is testing

BV-AVD-R Treatment Children Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma
Beijing Children's Hospital 44
Not applicableActive Not RecruitingNCT07676825
What this trial is testing

This Study Compares the Conventional Cutting Seton Technique and a GLUBRAN®-Coated Seton in High Perianal Fistula Treatment. The Study Aims to Determine Whether the GLUBRAN®-Coated Seton Improves Healing, Reduces Postoperative Pain and Recurrence, and Better Preserves Anal Continence.

Who this might be right for
Perianal Fistula
Kasr El Aini Hospital 36
Next Page